James Zimmerman, chairman of the American Chamber of Commerce in China, notes that more dialogue means greater clarity and predictability — helping reduce risks of disruptions.
James Zimmerman, Chairman at AmCham China, discusses the chamber’s latest business climate survey. According to the report, US companies are more upbeat about doing business in China following the trade truce between the two countries.
Tariffs, US sourcing of rare earth metals, and Chinese access to high-end US computer chips, have dominated talks between the two sides, but there are many other issues to be resolved when Xi hosts Trump in April, according to James Zimmerman who chairs the American Chamber of Commerce in China.
Earlier, we sat down with Michael Hart, president of the American Chamber of Commerce in China. Hart pointed to the role of APEC in strengthening bilateral dialogue and reaffirmed his confidence in the Chinese market.
Part of the challenge is that each side believes it has the upper hand, said Michael Hart, the president of the American Chamber of Commerce in China.
“稳定和相互理解符合各方利益。”何迈可仍然乐观地认为，即使在当今复杂的国际环境中，务实合作仍将继续。
Most US companies with operations in China aren’t planning to leave the country despite the challenges posed by tariffs, according to a survey late last month by the American Chamber of Commerce in China.
China’s push for high-tech self-sufficiency and industrial upgrading presents challenges as well as opportunities for US businesses, said Michael Hart, president of AmCham China, in a recent interview with China Daily.
在全球医药健康产业蓬勃发展的当下，中美两国作为医药领域的关键参与者，其间的合作交流备受瞩目。近期，国家卫生健康委员会百姓健康频道（CHTV）和医学论坛网联合对中国美国商会会长何迈可（Michael Hart）先生进行了独家专访，深入探讨了美国在华医药企业的发展现状、挑战应对以及未来合作前景等重要议题。
2025年4月28日下午，国家药品监督管理局副局长杨胜会见了来访的中国美国商会会长何迈可(Michael Hart)先生一行。